Class information for:
Level 1: TICLOPIDINE//TICLOPIDINE HYDROCHLORIDE//PCA 4230

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
21469 359 25.9 53%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
202 20434 CLOPIDOGREL//PRASUGREL//ASPIRIN RESISTANCE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TICLOPIDINE Author keyword 20 22% 22% 80
2 TICLOPIDINE HYDROCHLORIDE Author keyword 7 64% 2% 7
3 PCA 4230 Author keyword 1 50% 1% 2
4 TICLOPIDINE HCL Author keyword 1 100% 1% 2
5 TICLOPIDINE INDUCED CHOLESTASIS Author keyword 1 100% 1% 2
6 PROD LIFECYCLE MANAGEMENT Address 1 40% 1% 2
7 ANTI AGGREGATING DRUGS Author keyword 1 50% 0% 1
8 CARRETERA MAJADAHONDA POZUELO Address 1 50% 0% 1
9 CYTOCHROME P450 CYP 2C19 Author keyword 1 50% 0% 1
10 DERMATOL IDENCY TRAINING PROGRAM Address 1 50% 0% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 TICLOPIDINE 20 22% 22% 80 Search TICLOPIDINE Search TICLOPIDINE
2 TICLOPIDINE HYDROCHLORIDE 7 64% 2% 7 Search TICLOPIDINE+HYDROCHLORIDE Search TICLOPIDINE+HYDROCHLORIDE
3 PCA 4230 1 50% 1% 2 Search PCA+4230 Search PCA+4230
4 TICLOPIDINE HCL 1 100% 1% 2 Search TICLOPIDINE+HCL Search TICLOPIDINE+HCL
5 TICLOPIDINE INDUCED CHOLESTASIS 1 100% 1% 2 Search TICLOPIDINE+INDUCED+CHOLESTASIS Search TICLOPIDINE+INDUCED+CHOLESTASIS
6 ANTI AGGREGATING DRUGS 1 50% 0% 1 Search ANTI+AGGREGATING+DRUGS Search ANTI+AGGREGATING+DRUGS
7 CYTOCHROME P450 CYP 2C19 1 50% 0% 1 Search CYTOCHROME+P450+CYP+2C19 Search CYTOCHROME+P450+CYP+2C19
8 DISAGGREGANTS 1 50% 0% 1 Search DISAGGREGANTS Search DISAGGREGANTS
9 FRAGMENTATION HEMOLYSIS 1 50% 0% 1 Search FRAGMENTATION+HEMOLYSIS Search FRAGMENTATION+HEMOLYSIS
10 GAS CHROMATOGRAPHY MASS SPECTROMETRIC DETECTION 1 50% 0% 1 Search GAS+CHROMATOGRAPHY+MASS+SPECTROMETRIC+DETECTION Search GAS+CHROMATOGRAPHY+MASS+SPECTROMETRIC+DETECTION

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 INDUCED PROLONGED CHOLESTASIS 7 46% 3% 11
2 ASPIRIN STROKE 2 67% 1% 2
3 BYPASS GRAFT OCCLUSION 2 43% 1% 3
4 ANTIAGGREGANT THERAPY 1 50% 0% 1
5 GUANOSINE MONOPHOSPHATE PRODUCTION 1 50% 0% 1
6 INHIBITOR TICLOPIDINE 1 50% 0% 1
7 P4502C19 1 29% 1% 2
8 INTRACORONARY STENT PLACEMENT 1 25% 1% 2
9 CANADIAN AMERICAN TICLOPIDINE 1 22% 1% 2
10 PLATELET MEMBRANE PROTEIN 0 33% 0% 1

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Adverse haematological effects of ticlopidine - Prevention, recognition and management 1998 59 24 71%
CLINICAL PHARMACOKINETICS OF TICLOPIDINE 1994 60 26 73%
Drug evaluation - Ticlopidine - A review of its pharmacology, clinical efficacy and tolerability in the prevention of cerebral ischaemia and stroke 1996 30 72 63%
Ticlopidine-induced aplastic anemia and quick recovery with G-CSF: Case report and literature review 2000 7 10 90%
TICLOPIDINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN PLATELET-DEPENDENT DISEASE STATES 1987 197 74 68%
Ticlopidine-induced aplastic anemia: Report of three Chinese patients and review of the literature 1997 12 8 75%
TICLOPIDINE - AN UPDATED REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC USE IN PLATELET-DEPENDENT DISORDERS 1990 143 63 62%
TICLOPIDINE - A PROMISE FOR THE PREVENTION AND TREATMENT OF THROMBOSIS AND ITS COMPLICATIONS 1983 121 40 60%
TICLOPIDINE-INDUCED APLASTIC-ANEMIA - CASE-REPORT AND REVIEW OF THE LITERATURE 1995 8 10 70%
TICLOPIDINE - A NEW ANTIPLATELET AGENT FOR THE SECONDARY PREVENTION OF STROKE 1994 15 17 47%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 PROD LIFECYCLE MANAGEMENT 1 40% 0.6% 2
2 CARRETERA MAJADAHONDA POZUELO 1 50% 0.3% 1
3 DERMATOL IDENCY TRAINING PROGRAM 1 50% 0.3% 1
4 MED INFORMAT SYST MANAGEMENT 1 50% 0.3% 1
5 PMS PROD INFORMAT MANAGEMENT 1 50% 0.3% 1
6 SGOMC 1 50% 0.3% 1
7 JOHNSON CITY MED 0 33% 0.3% 1
8 UO EMATOL ONCOL 0 33% 0.3% 1
9 IST PATOL MED 1 0 15% 0.6% 2
10 CENT S 1948 YOSHINO 0 25% 0.3% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000151149 TRANSIENT ISCHEMIC ATTACK//ABCD2 SCORE//TIA
2 0.0000141326 9 ALLYLPURINES//ANTIPLATELET COMPOUNDS//HAMILTON GEN HOSP CLIN UNIT
3 0.0000116908 COAGULATION ABNORMALITY//D L LYSINACETYLSALICYLATE//SECT CLIN GERONTOL VASC MED
4 0.0000086201 AGRANULOCYTOSIS//DRUG INDUCED AGRANULOCYTOSIS//EVALUATION SCORE
5 0.0000080183 CLOPIDOGREL//PRASUGREL//TICAGRELOR
6 0.0000079191 DIFERENTIATION//HUMAN PANCREATIC CARCINOMA CELL LINES//LIVER SPECIFIC ANTIGEN
7 0.0000068654 COLD TARGET COMPETITION//COMPLEMENT DISTRIBUTION//DEFORMABILITY OF RED CELLS
8 0.0000062313 POSTVIRAL ENCEPHALITIS//RELAPSING HEPATITIS//RHEUMATOL METAB BONE JOINT DIS
9 0.0000061023 REACTIVE METABOLITE//MASS DEFECT FILTER//TIENILIC ACID
10 0.0000060882 EPTIFIBATIDE//TIROFIBAN//ABCIXIMAB